The innate immune system is evolutionally conserved, and it is the fi rst line of the defensive mechanisms for protecting the host from invading microbial pathogens ( 1 ) . Innate immune cells, including macrophages and dendritic cells, express a series of receptors known as Toll-like receptors (TLRs), which bind to highly conserved sequences expressed by microorganisms ( 2, 3 ) . LPS is an integral cell wall component of Gram-negative bacteria, and can provoke a lifethreatening condition called endotoxic shock. The infl ammatory response to LPS is mediated mainly by a receptor complex composed of LPSbinding protein CD14 and TLR4 ( 4 ) . Upon activation of TLR4, the cytoplasmic domains recruit signal adaptor molecules, such as MyD88 and Trif, which, in turn, trigger a cascade of signaling events leading to the activation of MAPKs and I B kinases (IKKs), as well as the downstream transcription factors AP-1, NF-B, and IRF3. Activation of NF-B and mitogen-activated protein kinases (MAPKs) by the MyD88-dependent pathway is essential for the transcription of a variety of proinfl ammatory cytokines, including TNF ␣ and IL-6, whereas the initial induction of type I IFN, e.g., IFN-␤ , is largely dependent on Trif-mediated IRF3 activation ( 5 ) . These proinfl ammatory cytokines can, in turn, stimulate the release of secondary mediators, which, if not properly controlled, may ultimately lead to dysfunction of multiple vital organs.
The optimal type and strength of the innate immune response can be regulated through a balance of activating and inhibitory signals that are delivered by receptors on the surface of cells of the innate immune system ( 6 ) . One such group of cell-surface receptors is the signal regulatory protein (SIRP) family. The fi rst and best-characterized member of the SIRP family, empty vector, introduction of shRNA or SIRP ␣ gene had little eff ect on cell growth during the time period examined ( Fig. 1 B ) . TLR stimulation activates IKKs and all three major subgroups of MAPK: c-Jun NH 2 -terminal kinase (JNK), p38 MAPK, and extracellular signal -related kinase (ERK) ( 2, 3 ) . In response to LPS, KD macrophages were found to exhibit enhanced phosphorylation of p38, JNK, ERK, and I B ␣ , whereas overexpression of SIRP ␣ resulted in reduction of these signaling pathways in RAW cells ( Fig. 1 C ) . Furthermore, transient transfection of siRNA directed against SIRP ␣ into thioglycollate-elicited peritoneal macrophages from C57BL/6 mice ( Fig. 1 D ) also resulted in higher activation of p38, JNK, ERK, and I B ␣ compared with that in macrophages transfected with negative control siRNA upon LPS stimulation ( Fig. 1 E ) . Because AP-1 and NF-B transcription factors are known targets of LPS-activated MAPKs and IKKs, we then examined whether SIRP ␣ aff ects AP-1 and NF-B activities. As revealed by a luciferase reporter assay, there were substantial increases in AP-1 and NF-B activities in SIRP ␣ -KD macrophages after LPS stimulation ( Fig. 1 F ) . Conversely, introduction of WT SIRP ␣ attenuated activation of AP-1 and NF-B reporter genes by LPS stimulation. These fi ndings demonstrate that SIRP ␣ negatively regulates LPS signaling by suppressing the MAPKs and NF-B pathways in macrophages.
SIRP ␣ knockdown alters the pattern of cytokine production in LPS-stimulated macrophages
Because MAPKs and NF-B signaling are pivotal in modulating innate immune responses, we investigate whether SIRP ␣ directly controls cytokine production in macrophages upon LPS treatment. SIRP ␣ -KD, -OV, and -VT macrophages were stimulated with various concentrations of LPS for 12 h to determine the production of cytokines or for 24 h for the nitric oxide (NO) in the conditioned medium. In response to LPS stimulation, SIRP ␣ -KD macrophages produced substantially more TNF ␣ , IL-6, and NO than SIRP ␣ -OV and -VT macrophages ( Fig. 2 A ) . As expected, SIRP ␣ -OV cells produced the least TNF ␣ , IL-6, and NO at any of the doses examined. To exclude the possibility that SIRP ␣ -KD macrophages might be compensatorily activated, thioglycollate-elicited peritoneal macrophages from C57BL/6 mice were used to assess the role of SIRP ␣ in cytokine production in primary macrophages. Similar to what was observed for SIRP ␣ -KD macrophages, peritoneal macrophages transfected with SIRP ␣ siRNA also mounted a more robust TNF ␣ , IL-6, and NO production than did negative control siRNA upon various doses of LPS stimulation ( Fig. 2 B ) , suggesting that no compensatory activation of macrophages occurs under SIRP ␣ -KD conditions.
To study the eff ects of SIRP ␣ on the production of comprehensive infl ammatory cytokines, SIRP ␣ -KD and -OV cells were stimulated with LPS for 12 h, and the conditioned medium was subjected to an antibody array of 40 mouse infl ammatory cytokines. As shown in Fig. 2 C , a substantial number of proinfl ammatory cytokines, including IL-6, TNF ␣ , MCP-1, MIP-1 ␣ , RANTES, and GCSF, were dramatically SIRP ␣ , is especially abundant in innate immune cells, including macrophages and dendritic cells ( 7, 8 ) . The extracellular region of SIRP ␣ is heavily glycosylated, and it has been shown to bind to either widely expressed transmembrane ligand CD47 ( 9 ) or soluble ligands, such as the surfactant proteins A and D, which are present at high levels in the lungs ( 10 ) . Interaction of CD47 with SIRP ␣ negatively regulates phagocytosis of host cells by macrophages ( 11 ) . Mice that lack the SIRP ␣ cytoplasmic domain are thrombocytopenic, which apparently results from an increased rate of clearance of circulating platelets ( 12, 13 ) . Nonopsonized erythrocytes from CD47 Ϫ / Ϫ mice are recognized and rapidly eliminated in WT recipients, and they are phagocytosed by WT macrophages in vitro ( 14 ) . This strongly suggests that SIRP ␣ acts to negatively control innate immune eff ector function. In lungs, ligation of SIRP ␣ on macrophages by surfactant proteins is required to keep the activity of alveolar macrophages in check, thus preventing damage to the airways caused by proinfl ammatory responses ( 10 ) . Therefore, SIRP ␣ induces well-characterized inhibitory signals in innate immune cells that can largely be reconciled by the association of tyrosine phosphatases with the cytoplasmic region ( 8, 15 ) . The cytoplasmic region of SIRP ␣ contains two immunoreceptor tyrosine-based inhibitory motifs with four tyrosine residues that are phosphorylated in response to a variety of growth factors and ligand binding. This phosphorylation enables recruitment of SHP-1 and -2 that, in turn, dephosphorylates specifi c protein substrates involved in mediating various physiological eff ects ( 8, 16, 17 ) . SIRP ␣ has been shown to negatively or positively regulate MAPK signaling initiated either by tyrosine kinasecoupled receptors for growth factors or by cell adhesion to extracellular matrix ( 8, 16 ) . Moreover, the expression of the dominant-negative form of SIRP ␣ stimulates NF-B activity and makes the cells resistant to TNF-specifi c apoptosis ( 18 ) . However, the role of SIRP ␣ in TLR-mediated signaling during innate immune responses has not been defi ned. We show that SIRP ␣ plays an essential role in negatively regulating LPS signaling at an early stage of TLR4 activation. LPS-induced SIRP ␣ reduction is required for initiation of MyD88-and Trif-dependent intracellular signaling pathways. Knockdown of SIRP ␣ leads to augmented production of proinfl ammatory cytokines and multiple organ failure, which is characteristic of severe sepsis after TLR activation. Thus, the expression level of SIRP ␣ may represent a threshold for control of a magnitude of host infl ammatory responses to microbial pathogens.
RESULTS

SIRP ␣ knockdown enhances TLR signaling in macrophages
To examine SIRP ␣ regulation of the innate immune responses during bacterial infection, we fi rst constructed a short hairpin RNA (shRNA) vector that specifi cally down-regulated SIRP ␣ and stably transfected it into RAW264.7 macrophage cells. RAW cells were also stably transfected with either WT SIRP ␣ (Myc-tagged) or an empty vector. They are referred to here as SIRP ␣ -KD (knockdown), -OV (overexpression), and -VT (vector) macrophages, respectively ( Fig. 1 A ) . Compared with element (ISRE) reporter activity was also increased in stably transfected RAW cell lines expressing shRNA for SIRP ␣ ( Fig. 2 G ) . Because initial induction of IFN-␤ is largely dependent on Trif-mediated IRF3 activation, we examined the phosphorylation of IRF3 upon LPS challenge and found that SIRP ␣ siRNA treatment evidently led to the enhanced LPSinduced IRF3 activation in mouse peritoneal macrophages ( Fig. 2 H ) . Collectively, our data clearly indicate that SIRP ␣ regulates the expression profi le of proinfl ammatory cytokines through both MyD88-and Trif-dependent pathways.
induced after LPS challenge. However, many antiinfl ammatory cytokines, such as IL-4 and -10, were not substantially altered. ELISA assays confi rmed that the production of MIP-1 ␣ and RANTES in the LPS-stimulated SIRP ␣ KD macrophages was, indeed, considerably higher than those in the LPS-stimulated SIRP ␣ -OV and -VT macrophages ( Fig. 2 D ) .
Interestingly, SIRP ␣ knockdown also substantially raised LPS-induced IFN-␤ production and mRNA expression in either RAW cell line or mouse peritoneal macrophages ( Fig.  2, E and F ) . In addition, the interferon-sensitive response stained with a fl uorescent vital dye, SP-DiI, which was systemically delivered in vivo. The cells were analyzed by light and fl uorescent microscopy in frozen sections 24 h after injection. As shown in Fig. 3 A , a large number of the injected RAW cells were found in the normal spleen, liver, and lung tissues, which is a typical distribution pattern for host-derived macrophages. Furthermore, the reconstituted mice showed a similar survival rate to the control normal mice after lethal dose challenge with LPS ( Fig. 3 B ) . These results may support Transferring with SIRP ␣ -KD macrophages increases susceptibility of mice to lethal LPS shock Because SIRP ␣ -KD macrophages exhibited a marked elevation in TNF ␣ , which plays an important role in the pathogenesis of septic shock ( 19 ), we asked whether mice transfered with SIRP ␣ -KD macrophages were more susceptible to LPSinduced toxicity. To determine whether RAW cells were capable of reconstituting macrophage-depleted allogeneic BALB/c mice (GdCl 3 pretreatment), RAW264.7 cells were TLR9 apparently occurred independently of SIRP ␣ expression. We also performed these studies with peritoneal macrophages transiently transfected with synthetic SIRP ␣ siRNA and obtained similar results ( Fig. 4 C ) . Thus, SIRP ␣ seems to regulate the magnitude and duration at the early " time window " of TLR-induced responses independently of previously described endotoxin tolerance mechanisms ( 20 ) .
LPS-induced SIRP ␣ reduction contributes to macrophage activation
To understand the cellular mechanisms by which SIRP ␣ controls LPS signaling, we fi rst examined whether SIRP ␣ could modulate the expression of TLR4, which is a functional receptor for LPS. By using immunoblot assay, we measured TLR4 expression in SIRP ␣ -KD, -OV, and -VT macrophages, or in peritoneal macrophages from C57BL/6 mice transfected with SIRP ␣ siRNA or negative control siRNA with or without LPS exposure for 12 h, and we found no detectable diff erence in TLR4 levels between the cells examined ( Fig. 5 A ) . We next analyzed SIRP ␣ protein and RNA levels after an initial LPS treatment in mouse macrophage cell lines (RAW 264.7 and J774A.1), as well as in mouse peritoneal macrophages. Fig. 5 B shows a pattern of rapid and persistent down-regulation of SIRP ␣ protein after LPS treatment in a time-and dosedependent manner. Quantitative real-time PCR analysis further showed that there was an approximately threefold reduction of SIRP ␣ RNA expression after 15 min of exposure to LPS, and that SIRP ␣ mRNA remained lower after 24 h ( Fig. 5 C ) . To determine whether the reduction in SIRP ␣ expression induced by LPS was also attributable to an increased rate of degradation, we examined the eff ects of inhibitors of protein degradation by lysosomes or the proteasome. MG132, which is a reversible peptide aldehyde that blocks proteasomal activity, had no marked eff ect on the ability of LPS to suppress SIRP ␣ expression. In contrast, prior treatment of RAW cells with chloroquine or NH 4 Cl, both of which inhibit lysosomal function, substantially attenuated the eff ect of LPS. On the other hand, treatment with cycloheximide (CHX) alone considerably suppressed the levels of SIRP ␣ protein, and LPS stimulation in the presence of CHX further down-regulated SIRP ␣ expression ( Fig. 5 D ) . Collectively, these data clearly indicate that, in addition to transcriptional repression of SIRP ␣ expression, LPS also induces the degradation of SIRP ␣ by the lysosome, thus contributing to the loss of SIRP ␣ protein in macrophages after LPS stimulation.
To determine the upstream signals responsible for the reduction of SIRP ␣ , we examined the expression of SIRP ␣ in mice lacking TLR4 (C57BL/10ScCr) or in mice with a missense mutation of TLR4 (C3H/HeJ) ( 21 ) . After LPS treatment, the reduction of SIRP ␣ expression was not observed in peritoneal macrophages from either TLR4 knockout or mutant mice, suggesting that TLR4 is required for LPS-induced SIRP ␣ down-regulation ( Fig. 5 E ) . Interestingly, SIRP ␣ protein levels were constitutively higher in peritoneal macrophages from C57BL/10ScCr or C3H/HeJ mice than in cells from control mice, indicating that basal TLR4 signaling activity is necessary for controlling the expression level of SIRP ␣ .
the feasibility of this model system. Next, age-and sex-matched cohorts of mice pretreated with GdCl 3 for 24 h were injected i.v with SIRP ␣ -KD, -OV, or -VT cells; after an additional 24 h, they were injected i.p. either with vehicle (PBS) or LPS. Survival of these animals was monitored over 4 -5 d. As shown in Fig. 3 C , none of the SIRP ␣ -KD, -OV, and -VT mice injected with PBS showed a diff erence on survival. However, at a LPS dose of 20 mg/kg body weight, mortality was observed within 14 h after LPS challenge for KD mice. By 24 h, Ͼ 50% of KD mice had died, whereas the fi rst mortality for VT mice occurred at 24 h. Although 85% death was noted for KD mice by the end of the experiment (120 h), only 26 and 35% of the OV and VT mice had died. Therefore, KD mice were more susceptible to LPS-induced lethality.
Endotoxic shock is mediated by an overproduction of proinfl ammatory cytokines, including TNF ␣ and IL-6. To examine whether SIRP ␣ controls cytokine release in response to LPS stimulation in vivo, we measured levels of various cytokines in the serum from mice after 3 h of LPS challenge. In the absence of LPS challenge, serum levels of TNF ␣ and IL-6 were at a very low level. In response to LPS challenge, serum TNF ␣ and IL-6 levels in KD mice were substantially elevated by Ͼ 3 -4 and 1.5 -2 times, respectively, of those in OV and VT mice ( Fig. 3 D ) .
To examine the eff ects of SIRP ␣ on the function of key organs, SIRP ␣ -KD, -OV, and -VT mice were challenged with LPS at a dose of 10 mg/kg body weight and killed 24 h after LPS injection. As shown in Fig. 3 E , KD mice challenged with LPS showed gross organ failure and severe infl ammatory infi ltrates in lung and liver, compared with OV and VT mice. Collectively, our results indicate that SIRP ␣ -KD mice are highly susceptible to the development of multiple organ failure syndromes after LPS administration, and that SIRP ␣ is required for the restriction of macrophage responses to LPS in vivo.
Endotoxin tolerance is SIRP ␣ independent
The aforementioned results, fi nding that SIRP ␣ down-regulated LPS-induced biological responses, prompted us to investigate whether SIRP ␣ is also important for mediating endotoxin tolerance, a transient state of LPS refractoriness after the initial, nonlethal exposure to LPS. To determine whether SIRP ␣ regulates the production of proinfl ammatory cytokines after LPS pretreatment, we fi rst treated SIRP ␣ -KD, -OV, and -VT macrophages with LPS for 24 h, after which we assessed IL-6 and TNF ␣ production during a subsequent 12-h LPS treatment, or 24-h treatment for NO. SIRP ␣ -KD cells substantially elaborated increased amounts of TNF ␣ , IL-6, and NO during the fi rst 12 h after exposure to LPS ( Fig. 4 A ) . Their production by all SIRP ␣ -KD, -OV, and -VT macrophages was considerably reduced after 24 h of LPS pretreatment, indicating that SIRP ␣ is not required for LPS-induced down-regulation of cytokine production. Similarly, stimulation of cells with CpG or LPS for 24 h, followed by a second 12 or 24 h of LPS or CpG treatment, also resulted in decreased IL-6, TNF ␣ , and NO production by all cells ( Fig. 4 B ) , suggesting that cross-tolerance between TLR4 and LPS treatment aff ected tyrosine phosphorylation of SIRP ␣ and its association with SHP-1 and -2 in macrophages. RAW264.7 cells were stimulated with LPS, and the endogenous SIRP ␣ was immunoprecipitated and subjected to immunoblot with respective antibodies. As shown in Fig. 6 A , LPS treatment induced tyrosine phosphorylation of SIRP ␣ , but failed SIRP ␣ is activated by LPS and binds constitutively to SHP-1 and -2 SIRP ␣ is a surface receptor containing immunoreceptor tyrosine -based inhibitory motif domains that are known to exert inhibitory functions through the recruitment of phosphatase enzymes SHP-1 and -2 ( 22 ) . Thus, we investigated whether Figure 4 . SIRP ␣ is not required for endotoxin tolerance. (A) 5 ϫ 10 5 cells/well SIRP ␣ -KD, -OV, and -VT cells were untreated or tolerized with 100 ng/ml LPS for 24 h, washed, and rechallenged with 100 ng/ml LPS. After 12 h of incubation, the media were assessed for TNF ␣ and IL-6, and for NO levels after 24 h. Data are presented as the mean Ϯ the SEM of 3 -8 independent experiments. (B) 5 ϫ 10 5 cells/well SIRP ␣ -KD, -OV, and -VT cells were tolerized with LPS or CpG for 24 h, washed, and rechallenged with the indicated doses of LPS or CpG. TNF ␣ , IL-6, and NO levels were determined as described in A. (C) 3 ϫ 10 5 cells/well peritoneal macrophages from C57BL/6 mice were transfected with either control or SIRP ␣ siRNA. 24 h later, cells were tolerized with LPS or CpG for 24 h, washed, and rechallenged with the indicated doses of LPS or CpG. TNF ␣ , IL-6, and NO levels were determined as described in A.
The data are representative of two independent experiments with similar results. (C) More lethality in mice transfered with SIRP ␣ -KD cells challenged with LPS. Age-and sex-matched cohorts of mice ( n ϭ 7) were pretreated with GdCl 3 (10 mg/kg of body weight), and 24 h later were i.v. injected with SIRP ␣ -KD, -OV, and -VT cells (10 7 /each). Another 24 h later, mice were i.p. administered with PBS or 20 mg LPS/kg of body weight, and lethality was observed over 120 h after this challenge. The data are representative of two independent experiments with similar results. (D) Sera from mice pretreated as described in A and injected with PBS or LPS (10 mg/kg of body weight) were collected at 3 h after the challenge, and IL-6 and TNF ␣ levels were measured by ELISA. Data show the mean Ϯ the SEM for three mice from each group. *, P Ͻ 0.05; **, P Ͻ 0.01 (OV or KD different from VT). (E) Severe multiple organ failure in mice transfered with SIRP ␣ -KD cells challenged with LPS. Representative images of lung and liver with histological sections from mice pretreated as described in C and killed at 24 h after LPS administration (10 mg/kg weight body). Bars, 100 m.
In addition, PP 2 also blocked LPS-induced SIRP ␣ phosphorylation, indicating that such phosphorylation of SIRP ␣ is mainly mediated by Src kinases ( Fig. 6 C ) .
SHP-1 is generally considered a negative signal transducer, whereas SHP-2 is considered a positive one ( 25 ) . However, the precise role of each enzyme in shared signaling pathways during innate immune activation is not well defi ned. To examine their roles in LPS-mediated signaling, SHP-1 and -2 expression were separately knocked down by siRNAs in to enhance SHP-1 and -2 recruitment. Interestingly, SHP-1 and -2 were found to be constitutively associated with SIRP ␣ in macrophages ( Fig. 6 A ) , which coincided with the results of previous studies ( 23, 24 ) . However, treatment of RAW cells with either the Src-specifi c inhibitor PP 2 or universal tyrosine kinase inhibitor Genistein nearly abrogated the constitutive association of SIRP ␣ with SHP-1 or -2, which suggests that the basal association of SHP proteins is dependent on the undetectable phosphorylation of SIRP ␣ ( Fig. 6 B ) . 4 Cl, 40 M MG132, or 50 g/ml CHX, after which they were treated with or without 100 ng/ml LPS for 5 h and subjected to Western blot analysis using SIRP ␣ -specifi c antibody. (E) TLR4 is essential for the down-regulation of SIRP ␣ . Peritoneal macrophages from TLR4 KO (C57BL/10ScCr) and littermate WT1 (C57BL/10snj) mice or TLR4 mutant (C3H/HeJ) and littermate WT2 (C3H/Heouj) mice were incubated with 100 ng/ml LPS for the indicated times, and SIRP ␣ protein expression was determined by Western blot analysis.
p38, whereas knockdown of SHP-2 slightly reduced their activities ( Fig. 6 G ) .
To elucidate whether SHP-1 and -2 contribute to the inhibitory function of SIRP ␣ in macrophage activation, peritoneal macrophages were cotransfected with SIRP ␣ and SHP-1 siRNAs or SIRP ␣ and SHP-2 siRNAs to eliminate both proteins simultaneously. After LPS stimulation, the conditioned medium was analyzed for cytokine production. As shown in Fig. 6 H , knockdown of SHP-1, together with SIRP ␣ , slightly increased the production of TNF ␣ and IL-6 more than knockdown of SIRP ␣ alone, suggesting a synergetic role of peritoneal macrophages ( Fig. 6 D ) with subsequent LPS treatment, and the production of TNF ␣ and IL-6 was analyzed using ELISA assay. As expected, knockdown of SHP-1 caused an ‫ف‬ 20% increase in cytokine production, whereas knockdown of SHP-2 resulted in a nearly twofold lower production of TNF ␣ and IL-6 ( Fig. 6 E ) . Further analysis of IFN-␤ production in SHP-1 and -2 siRNA-transfected cells reveals that SHP-2 plays a critical role in positive regulation of LPS-induced Trif signaling, whereas SHP-1 has no marked eff ect on the pathway ( Fig. 6 F ) . In addition, knockdown of SHP-1 enhanced the activation of ERK and Western blot analysis demonstrates the effects of siRNAs that specifi cally downregulate SHP-1 or -2 expression in peritoneal macrophages. (E) Peritoneal macrophages transfected with SHP-1 -or -2 -specifi c siRNAs were stimulated with 100 ng/ml LPS for 12 h, and the production of TNF ␣ and IL-6 was determined using ELISA. Data are presented as the mean Ϯ the SEM of 3 -6 independent experiments. *, P Ͻ 0.05; **, P Ͻ 0.01 (SHP-1 or SHP2 siRNA different from negative control siRNA). (F) IFN-␤ production after LPS challenge in peritoneal macrophages. 3 ϫ 10 5 cells/well transfected with SHP-1 -or -2 -specifi c siRNAs was analyzed as in E. *, P Ͻ 0.05; **, P Ͻ 0.01 (SHP-1 or -2 siRNA different from negative control siRNA). (G) Peritoneal macrophages transfected with SHP-1 or -2 siRNAs or negative control oligonucleotides were stimulated with 10 ng/ml of LPS for the indicated times. Cell lysates were blotted with the indicated antibodies. (H) Peritoneal macrophages were transfected with SIRP ␣ -specifi c siRNA alone or together with SHP-1 -or -2 -specifi c siRNAs with subsequent LPS stimulation. The production of TNF ␣ and IL-6 were determined as described in E. *, P Ͻ 0.05; **, P Ͻ 0.01 (SIRP1 ␣ /SHP-1 or SHP-2 double-knockdown is different from SIRP1 ␣ knockdown alone). (I) Rescue of cytokine production by reintroduction of WT SIRP ␣ . 2 ϫ 10 6 cells/well SIRP ␣ -KD cells transfected with GFP, WT SIRP ␣ (WT), or its mutant form SIRP ␣ -4F (4F) were treated with 100 ng/ml LPS. The amounts of secreted TNF ␣ and IL-6 in supernatants were determined by ELISA as described in E. Data are the mean Ϯ the SEM of three independent experiments. **, P Ͻ 0.01 (WT different from GFP).
during TLR activation. First, LPS-induced SIRP ␣ down-regulation is required for the initiation of macrophage responses because introduction of SIRP ␣ induces inability to respond to LPS in RAW cells, whereas depletion of SIRP ␣ results in hypersusceptibility to LPS. Second, the SIRP ␣ -mediated inhibition of TLR signal functions independently of endotoxin tolerance mechanisms, which is consistent with the rapid and sustained decrease in SIRP ␣ levels after LPS challenge. Thus, it appears that SIRP ␣ is not a component of a feedback regulatory system of innate immunity. Instead, SIRP ␣ more likely operates at an early " time window " of TLR-induced responses. Third, depletion of SIRP ␣ causes a substantial induction of proinfl ammatory cytokine expression upon LPS exposure, whereas most antiinfl ammatory cytokines are not considerably aff ected. Compared with the release of proinfl ammatory cytokines, which occurs rapidly after TLR stimulation, production of antiinfl ammatory cytokines is considerably slower. This further indicates that SIRP ␣ -mediated repression is an early signaling event during TLR activation. Finally, LPS-induced activation of the MAPKs and NF-B pathways is reversely proportional to SIRP ␣ expression level, which strongly suggests that the negative regulation of TLR signals by SIRP ␣ may occur at a receptor-proximate level upstream of multiple signaling pathways. Given all the evidence obtained so far, our results raise the possibility that the expression level of SIRP ␣ may represent a threshold factor for septic shock. SIRP ␣ and SHP-1 in suppressing LPS signaling. Conversely, knockdown of SHP-2 nearly reversed the hyperresponsive eff ects induced by SIRP ␣ depletion in response to LPS, which indicate that SIRP ␣ mainly functions through its association and sequestration of SHP-2 to prevent LPS-induced macrophage activation. In addition, transient overexpression of WT SIRP ␣ into SIRP ␣ -knockdown RAW cells restrained LPS-induced cytokine production, whereas its mutant form, SIRP ␣ -4F, which is incapable of binding to SHP-2, was unable to restore SIRP ␣ -mediated repression of LPS-inducible cytokine genes ( Fig. 6 I ) . These data further indicate that SIRP ␣ acts via SHP-2 sequestration to negatively regulate TLR4 signaling.
SIRP ␣ prevents LPS responses through sequestration of SHP-2 from IKKs
As a previous study indicates that SHP-2 is an integral component of the IKK complex, and a functional SHP-2 is required for effi cient phosphorylation of I B by the IKK complex in cellular response to IL-1/TNF ( 26 ), we next searched for physical evidence for SHP-2 involvement in the MyD88 and Trif pathways by coimmunoprecipitation experiments. As expected, LPS induced interaction of endogenous SHP-2 with IKK ␤ and the IKK-like kinase TANK-binding kinase 1 (TBK1)/NAK ( Fig. 7 A ) , both of which are critically important for activation of MyD88-and Trif-dependent signaling, respectively ( 27, 28 ) . In contrast, SHP-1 could not be found in a complex with IKK (not depicted). Interestingly, compared with empty vectortransfected RAW cells, SIRP ␣ knockdown drastically enforced LPS-induced SHP-2 -IKK association ( Fig. 7 B ) , which strongly suggests that SIRP ␣ may compete with IKKs to bind SHP-2, thus compromising the essential role of SHP-2 in LPS signaling activation.
DISCUSSION
A dynamic balance between activation and repression of the innate immunity is of critical importance in the host immunological defenses. Under conditions of LPS exposure, multiple feedback mechanisms exist for restraining the strength and duration of the transduced signals, and the production of infl ammatory cytokines, which include the down-regulation of surface TLR expression, transcriptional induction of negative regulators such as IL-1 receptor -associated kinase (IRAK-M), suppressor of cytokine signaling 1 (SOCS1), SH2-containing inositol phosphatase, MyD88s, and antiinfl ammatory cytokines, mainly IL-10 and TGF-␤ ( 20 ) . Although these mechanisms probably play a prominent role in termination of TLR signals, the factors that restrict initiation of TLR-mediated responses remain largely unknown. Our results demonstrate that SIRP ␣ also acts as a crucial negative regulator of the innate immune responses both in vivo and in vitro. However, unlike the induction of other inhibitory proteins, SIRP ␣ is rapidly downregulated in response to LPS, which places it in the fi eld of the hitherto poorly understood negative regulatory mechanisms dictating the activation of innate immune responses. Multiple lines of evidence support such an early inhibitory role of SIRP ␣ However, the molecular basis for SHP ' s activities in the NF-kB pathway is not yet fully understood. We show that SHP-2, but not SHP-1 (not depicted), forms an inducible complex with IKK ␤ or TBK1 upon stimulating TLR4 with LPS, which appears to be required for NF-B and IRF3 activation, as the enforced SHP-2 -IKK associations after SIRP ␣ knockdown are accompanied by the increased phosphorylation of I B ␣ and IRF3. Because SIRP ␣ preferentially associates with, and most probably sequesters, SHP-2, which is required for both MAPK and IKK activities, it most likely acts at the level of this phosphatase to negatively regulate TLR signaling.
TLR-induced cytokine production in innate immune cells is mediated mainly by MAPK-and IKK-dependent signals. By inactivating these two pathways, SIRP ␣ determines the window of synthesis of a variety of proinfl ammatory cytokines, including TNF ␣ and IL-6. However, unlike other negative regulators, such as IRAK-M or SOCS1, depletion of SIRP ␣ has no signifi cant eff ect on IL-1 and IL-12p40 production after LPS challenge ( Fig. 2 C ) , and both IL-1 and IL-12p40 are known to contribute to the lethal outcome of endotoxin shock. Furthermore, it appears that LPS induces a much more dramatic release of TNF ␣ and IL-6 in SIRP ␣ -KD macrophages than in IRAK-M -or SOCS1-defi cient macrophages ( 33, 34 ) . These results perhaps refl ect the diff erent mechanisms on which these regulators operate. Interestingly, it has been shown that ligation of SIRP ␣ with monoclonal antibody results in modest reduction of TNF ␣ production, possibly via inducing intracellular retention of the cytokine, but has no eff ect on other cytokine induction in response to LPS stimulation ( 35 ) , which is inconsistent with the broad and drastic augmentation of proinfl ammatory cytokines in SIRP ␣ -depleted macrophages after LPS challenge. Considering that both MAPKs and IKKs positively regulate TNF ␣ synthesis ( 36, 37 ) , knockdown of SIRP ␣ may mainly enhance both the stability and the translation of TNF ␣ mRNA, rather than modulate its secretion. It has been suggested that SIRP ␣ ligation may trigger signal cascades other than MPAKs or IKKs; e.g., the PI3K pathway to specifi cally reduce TNF ␣ release. In addition, SIRP ␣ ligation has also been shown to induce macrophages to produce NO, thus indicating a positive eff ect of SIRP ␣ ( 23 ). However, the level of H 2 O 2 is increased after SIRP ␣ ligation, and is found to be essential for the SIRP ␣ -induced production of NO, so it is diffi cult to distinguish between eff ects that result from a direct activation of SIRP ␣ signaling or an indirect activation as a consequence of increased ROS production, or both. Future studies should elucidate more precisely whether and how these pathways integrate and translate into the various cellular functions that are regulated by SIRP ␣ in macrophages and other cells.
In summary, we have shown that SIRP ␣ plays a critically negative role in macrophage activation. LPS-induced SIRP ␣ down-regulation is required for inducing optimal strength and duration of the TLR signaling. SIRP ␣ therefore functions as a " homeostatic " eff ector in innate immunity. The basal level of SIRP ␣ in macrophages may represent a threshold for maintaining a non-/antiinfl ammatory environment. SIRP ␣ is likely to become a rational pharmacological target for A notable feature of SIRP ␣ is its ability to recruit and signal via the tyrosine phosphatases SHP-1 and -2. Therefore, it is likely that this feature is important for the negative regulatory role of SIRP ␣ in LPS-activated signaling. Although structurally very similar, these two phosphatases play quite diff erent cellular roles. SHP-1 has been generally considered as a negative signal transducer, essentially as an antagonist of SHP-2. The data presented here suggests that SHP-1 plays a relatively minor role in suppressing LPS-induced TLR activation, which is consistent with a recent study that SHP-1 modestly inhibits LPS-mediated TNF ␣ and iNOS production in mouse macrophages ( 29 ) . As double-knockdown of SHP-1 and SIRP ␣ induced a little more cytokine production than knockdown of SIRP ␣ alone, SHP-1 may represent a collaborating event in SIRP ␣ -mediated negative regulation of TLR signaling. On the other hand, our data provide direct evidence that SHP-2 plays a largely positive-signaling role in macrophage activation by LPS. By analyzing immune responses in macrophages lacking both SHP-2 and SIRP ␣ expression, we propose a model in which SIRP ␣ plays reciprocating roles in the temporal regulation of both pro-and antiinfl ammatory responses. In the initial phase of activation, macrophages have relatively high levels of SIRP ␣ protein, which probably acts as a scaff olding molecule to recruit SHP-2 in the vicinity of the cell membrane, thus preventing SHP-2 from activating downstream signaling pathways. Subsequently, the decrease in SIRP ␣ levels causes a disassociation of SHP-2 with SIRP ␣ , thus making SHP-2 available to mediate TLR signaling activation.
All TLRs are known to elicit conserved infl ammatory pathways, culminating in the activation of two major kinasemediated signaling pathways: the MAPK and IKK complexes, which transduce various upstream signals to the activation of AP-1, NF-B, and IRF3 transcription factors. Both SHP-1 and -2 have been shown to be necessary for growth factorinduced MAPK activation ( 30 ) . However, whether SHP-1 and -2 regulate LPS-induced MAPK activation remains unknown. By knocking down the expression of SHP-1 and -2, we demonstrate that SHP-1 exerts inhibitory eff ects on MAPK activation, which is inconsistent with the observation that ERK activation occurred normally in mev/mev cells in response to LPS ( 17 ) . It is likely that experimental variations in these experiments explain the diff ering results. In contrast, SHP-2 is seemingly indispensable for MAPK activation, as depletion of SHP-2 reduces macrophage responses to LPS. Previously, the eff ects of SIRP ␣ on growth factor -induced MAPK activation in epithelial or fi broblast cells have been controversially reported ( 15 ) . We clearly show that SIRP ␣ negatively regulates LPS-induced MAPK activation in macrophages. Given that SHP-1 is highly expressed in macrophages and, at a much lower level, in epithelial or fi broblast cells, whereas SHP-2 is expressed in the opposite manner, it is possible that the dynamic interaction of SIRP ␣ with SHP-1 and -2 is crucial for proper regulation of the MAPKs by LPS or some growth factors in cells derived from diff erent tissues. In addition to MAPKs, the NF-B pathway is also regulated either positively by SHP-2 ( 26, 31 ) or negatively by SHP-1 ( 18, 32 ) .
Cytokine assay. Cytokine levels in culture supernatants or in sera were determined using commercial ELISA kits for TNF ␣ , IL-6 (R & D Systems and BD Biosciences), RANTES, MIP-1 ␣ , and IFN ␤ (Biosource) according to the manufacturer ' s instructions. Each value represents the mean of triplicate values. Comprehensive analysis of cytokine levels were performed by using commercially available RayBio Mouse Infl ammation Antibody Array 1.1 (RayBiotech, Inc.) according to manufacturer ' s protocol.
Nitrite oxidant detection. Cells plated at 1.5 ϫ 10 5 cells/well in 24-well culture dishes were incubated overnight before stimulation. After the cells were treated with 100 ng/ml LPS for 24 h, culture medium was collected for analysis by the Griess Reagent kit. Nitrite concentrations were determined by the measurement of the optical density at 570 nm.
Luciferase assay. SIRP ␣ -KD/-OV/-VT RAW264.7 macrophages were plated at 5 ϫ 10 4 cells/well in 48-well culture dishes and were transfected with 0.2 g NF-B-Luc, AP-1-Luc, or ISRE-Luc reporter plasmids together with 0.02 g of pRL-TK (Promega) by GENEPORTER (Genlantis). Luciferase activity was detected by Dual-Luciferase Reporter Assay System (Promega). Relative luciferase activity was normalized with Renilla luciferase activity.
RT-PCR. RNA was extracted from RAW264.7 cells by using Trizol Reagent (Invitrogen). 2 g cellular RNA was used for cDNA synthesis. For real-time PCR, we used the specifi c SYBR-Fluo from TaKaRa Biotechnology Co. Ltd. PCR primers for detecting mRNA of SIRP ␣ and ␤ -actin were synthesized by TaKaRa (Biotechnology Co., Ltd.). PCR reaction consisted of 95 ° C for 1 min, 57 ° C for 1 min, 72 ° C for 1 min, ϫ 35 cycles for both ␤ -actin and SIRP ␣ . Primer sequences were as follows: ␤ -actin, sense, 5 Ј -GGACTCCTATGT-GGGTGGCGAGG-3 Ј , antisense, 5 Ј -GGGAGAGCATGCCCTCGTA-GAT-3 Ј ; and SIRP ␣ , sense, 5 Ј -TCGAGTGATCAAGGGAGCAT-3 Ј , antisense, 5 Ј -CCTGGACACTAGCATACTCTGAG-3 Ј .
